These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25175001)

  • 1. Technologies and strategies to characterize and quantitate metabolites in drug discovery and development.
    Ravindran S; Jadhav A; Surve P; Lonsane G; Honrao P; Nanda B
    Biomed Chromatogr; 2014 Nov; 28(11):1547-53. PubMed ID: 25175001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
    Liu ZY
    J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
    Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
    J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography coupled to mass spectrometry for metabolite profiling in the field of drug discovery.
    Saurina J; Sentellas S
    Expert Opin Drug Discov; 2019 May; 14(5):469-483. PubMed ID: 30810397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput liquid chromatography/mass spectrometry method for the quantitation of small molecules using accurate mass technologies in supporting discovery drug screening.
    Ding X; Ghobarah H; Zhang X; Jaochico A; Liu X; Deshmukh G; Liederer BM; Hop CE; Dean B
    Rapid Commun Mass Spectrom; 2013 Feb; 27(3):401-8. PubMed ID: 23280971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of polar metabolites by hydrophilic interaction chromatography--MS/MS.
    Jian W; Xu Y; Edom RW; Weng N
    Bioanalysis; 2011 Apr; 3(8):899-912. PubMed ID: 21510763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent development in liquid chromatography/mass spectrometry and emerging technologies for metabolite identification.
    Liang Y; Wang G; Xie L; Sheng L
    Curr Drug Metab; 2011 May; 12(4):329-44. PubMed ID: 21395529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of mass spectrometry in drug metabolism: 50 years of progress.
    Wen B; Zhu M
    Drug Metab Rev; 2015 Feb; 47(1):71-87. PubMed ID: 25639893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging and spatially resolved quantification of drug distribution in tissues by mass spectrometry.
    Prideaux B; Lenaerts A; Dartois V
    Curr Opin Chem Biol; 2018 Jun; 44():93-100. PubMed ID: 29957376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology.
    Maurer HH
    Ther Drug Monit; 2010 Jun; 32(3):324-7. PubMed ID: 20418802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches.
    Liu DQ; Hop CE
    J Pharm Biomed Anal; 2005 Feb; 37(1):1-18. PubMed ID: 15664738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking problems and possible solutions in the quantitative determination of small molecule drugs and metabolites in biological fluids using liquid chromatography-mass spectrometry.
    Bakhtiar R; Majumdar TK
    J Pharmacol Toxicol Methods; 2007; 55(3):262-78. PubMed ID: 17174577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current applications of liquid chromatography/mass spectrometry in pharmaceutical discovery after a decade of innovation.
    Ackermann BL; Berna MJ; Eckstein JA; Ott LW; Chaudhary AK
    Annu Rev Anal Chem (Palo Alto Calif); 2008; 1():357-96. PubMed ID: 20636083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel LC-MS approach for the detection of metabolites in DMPK studies.
    Plumb RS; Mather J; Little D; Rainville PD; Twohig M; Harland G; Kenny DJ; Nicholson JK; Wilson ID; Kass IJ
    Bioanalysis; 2010 Oct; 2(10):1767-78. PubMed ID: 21083328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of relative MS response factors of drug metabolites for semi-quantitative assessment of chemical liabilities in drug discovery.
    Blanz J; Williams G; Dayer J; Délémonté T; Gertsch W; Ramstein P; Aichholz R; Trunzer M; Pearson D
    J Mass Spectrom; 2017 Apr; 52(4):210-217. PubMed ID: 28152561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hazards in chromatographic bioanalysis method development and applications.
    Hooshfar S; Bartlett MG
    Biomed Chromatogr; 2017 Jan; 31(1):. PubMed ID: 27696464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry.
    Katsila T; Siskos AP; Tamvakopoulos C
    Mass Spectrom Rev; 2012; 31(1):110-33. PubMed ID: 21698655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification and rapid metabolite identification in drug discovery using API time-of-flight LC/MS.
    Zhang N; Fountain ST; Bi H; Rossi DT
    Anal Chem; 2000 Feb; 72(4):800-6. PubMed ID: 10701265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.